AAAAAA

   
Results: 1-11 |
Results: 11
USE OF THE WEI-LIN-WEISSFELD-METHOD FOR THE ANALYSIS OF A RECURRING AND A TERMINATING EVENT
Authors: LI QH LAGAKOS SW
Citation: Qh. Li et Sw. Lagakos, USE OF THE WEI-LIN-WEISSFELD-METHOD FOR THE ANALYSIS OF A RECURRING AND A TERMINATING EVENT, Statistics in medicine, 16(8), 1997, pp. 925-940
NONPARAMETRIC-INFERENCE OF A FAILURE TIME DISTRIBUTION WHEN THE FAILURE TIMES ARE ESTIMATED
Authors: KIM HJM LAGAKOS SW
Citation: Hjm. Kim et Sw. Lagakos, NONPARAMETRIC-INFERENCE OF A FAILURE TIME DISTRIBUTION WHEN THE FAILURE TIMES ARE ESTIMATED, Statistics in medicine, 15(21-22), 1996, pp. 2475-2490
A COMPARISON OF IMMEDIATE WITH DEFERRED ZIDOVUDINE THERAPY FOR ASYMPTOMATIC HIV-INFECTED ADULTS WITH CD4 CELL COUNTS OF 500 OR MORE PER CUBIC MILLIMETER
Authors: VOLBERDING PA LAGAKOS SW GRIMES JM STEIN DS ROONEY J MENG TC FISCHL MA COLLIER AC PHAIR JP HIRSCH MS HARDY WD BALFOUR HH REICHMAN RC
Citation: Pa. Volberding et al., A COMPARISON OF IMMEDIATE WITH DEFERRED ZIDOVUDINE THERAPY FOR ASYMPTOMATIC HIV-INFECTED ADULTS WITH CD4 CELL COUNTS OF 500 OR MORE PER CUBIC MILLIMETER, The New England journal of medicine, 333(7), 1995, pp. 401-407
ASSESSING DRUG COMPLIANCE USING LONGITUDINAL MARKER DATA, WITH APPLICATION TO AIDS
Authors: KIM HM LAGAKOS SW
Citation: Hm. Kim et Sw. Lagakos, ASSESSING DRUG COMPLIANCE USING LONGITUDINAL MARKER DATA, WITH APPLICATION TO AIDS, Statistics in medicine, 13(19-20), 1994, pp. 2141-2153
THE DURATION OF ZIDOVUDINE BENEFIT IN PERSONS WITH ASYMPTOMATIC HIV-INFECTION - PROLONGED EVALUATION OF PROTOCOL-019 OF THE AIDS-CLINICAL-TRIALS-GROUP
Authors: VOLBERDING PA LAGAKOS SW GRIMES JM STEIN DS BALFOUR HH REICHMAN RC BARTLETT JA HIRSCH MS PHAIR JP MITSUYASU RT FISCHL MA SOEIRO R
Citation: Pa. Volberding et al., THE DURATION OF ZIDOVUDINE BENEFIT IN PERSONS WITH ASYMPTOMATIC HIV-INFECTION - PROLONGED EVALUATION OF PROTOCOL-019 OF THE AIDS-CLINICAL-TRIALS-GROUP, JAMA, the journal of the American Medical Association, 272(6), 1994, pp. 437-442
ESTIMATION OF THE INFECTION TIME AND LATENCY DISTRIBUTION OF AIDS WITH DOUBLY CENSORED-DATA
Authors: GOMEZ G LAGAKOS SW
Citation: G. Gomez et Sw. Lagakos, ESTIMATION OF THE INFECTION TIME AND LATENCY DISTRIBUTION OF AIDS WITH DOUBLY CENSORED-DATA, Biometrics, 50(1), 1994, pp. 204-212
THE PROBABILITY THAT A PARTICULAR MALIGNANCY MAY HAVE BEEN CAUSED BY A SPECIFIED IRRADIATION - NCRP STATEMENT-7
Authors: LAGAKOS SW SAENGER EL
Citation: Sw. Lagakos et El. Saenger, THE PROBABILITY THAT A PARTICULAR MALIGNANCY MAY HAVE BEEN CAUSED BY A SPECIFIED IRRADIATION - NCRP STATEMENT-7, Radiation research, 134(3), 1993, pp. 394-396
THE PROBABILITY THAT A PARTICULAR MALIGNANCY MAY HAVE BEEN CAUSED BY A SPECIFIED IRRADIATION - NCRP STATEMENT-7 - COMMENT
Authors: LAGAKOS SW
Citation: Sw. Lagakos, THE PROBABILITY THAT A PARTICULAR MALIGNANCY MAY HAVE BEEN CAUSED BY A SPECIFIED IRRADIATION - NCRP STATEMENT-7 - COMMENT, Radiation research, 134(3), 1993, pp. 396-396
SIZE AND POWER OF 2-SAMPLE TESTS OF REPEATED-MEASURES DATA
Authors: DAWSON JD LAGAKOS SW
Citation: Jd. Dawson et Sw. Lagakos, SIZE AND POWER OF 2-SAMPLE TESTS OF REPEATED-MEASURES DATA, Biometrics, 49(4), 1993, pp. 1022-1032
ANALYZING DOUBLY CENSORED-DATA WITH COVARIATES, WITH APPLICATION TO AIDS
Authors: KIM MY DEGRUTTOLA VG LAGAKOS SW
Citation: My. Kim et al., ANALYZING DOUBLY CENSORED-DATA WITH COVARIATES, WITH APPLICATION TO AIDS, Biometrics, 49(1), 1993, pp. 13-22
CD4-INFECTION TAKING ZIDOVUDINE( LYMPHOCYTES ARE AN INCOMPLETE SURROGATE MARKER FOR CLINICAL PROGRESSION IN PERSONS WITH ASYMPTOMATIC HIV)
Authors: CHOI SS LAGAKOS SW SCHOOLEY RT VOLBERDING PA
Citation: Ss. Choi et al., CD4-INFECTION TAKING ZIDOVUDINE( LYMPHOCYTES ARE AN INCOMPLETE SURROGATE MARKER FOR CLINICAL PROGRESSION IN PERSONS WITH ASYMPTOMATIC HIV), Annals of internal medicine, 118(9), 1993, pp. 674-680
Risultati: 1-11 |